Disclosure Of Entity's Operating Segments [Text Block]

Zealand Pharma - Filing #1382971

Concept As at
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
2022-01-01 to
2022-12-31
As at
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2021-01-01 to
2021-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
2020-01-01 to
2020-12-31
Disclosure of entity's operating segments [text block]
Disclosure of operating segments [text block]
Disclosure of operating segments [abstract]
Disclosure of operating segments [line items]
Revenue
103,986,000 EUR
108,546,000 EUR
192,001,000 EUR
Tax expense (income)
6,431,000 EUR
3,949,000 EUR
4,814,000 EUR
Profit (loss) before tax
972,041,000 EUR
758,887,000 EUR
673,527,000 EUR
Profit (loss) from continuing operations
965,610,000 EUR
754,938,000 EUR
668,713,000 EUR
Profit (loss)
0 EUR
1,202,135,000 EUR
1,202,135,000 EUR
0 EUR
0 EUR
0 EUR
1,018,149,000 EUR
1,018,149,000 EUR
0 EUR
846,729,000 EUR
0 EUR
846,729,000 EUR
Assets
1,539,806,000 EUR
2,067,629,000 EUR
Liabilities
723,895,000 EUR
1,139,826,000 EUR
Cash flows from (used in) operating activities
942,209,000 EUR
1,211,971,000 EUR
688,716,000 EUR
Cash flows from (used in) investing activities
281,259,000 EUR
18,121,000 EUR
196,807,000 EUR
Cash flows from (used in) financing activities
587,398,000 EUR
1,332,751,000 EUR
760,941,000 EUR
Disclosure of products and services [text block]
Disclosure of products and services [abstract]
Disclosure of products and services [line items]
Disclosure of geographical areas [text block]
Disclosure of geographical areas [abstract]
Disclosure of geographical areas [line items]
Disclosure of major customers [text block]
Disclosure of major customers [abstract]
Disclosure of major customers [line items]

Talk to a Data Expert

Have a question? We'll get back to you promptly.